EP4159217
Samsetning sem inniheldur MEK hindra og B-Raf hindra
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
15.10.2010EP published:
22.5.2024EP application number:
22189749.9
EP translation filed:
12.8.2024Grant published:
15.9.2024EPO information:
European Patent Register
Max expiry date:
14.10.2030Expiry date:
14.10.2025Next due date:
31.10.2025
Title in English:
COMBINATION COMPRISING AN MEK INHIBITOR AND A B-RAF INHIBITORLanguage of the patent:
English
Timeline
Today
15.10.2010EP application
22.5.2024EP Publication
12.8.2024Translation submitted
15.9.2024Registration published
14.10.2025Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056 Basel, CH
Inventor
Name:
Dumble, MelissaAddress:
Collegeville, 19426, US
Name:
Kumar, RakeshAddress:
Collegeville, 19426, US
Name:
Laquerre, SylvieAddress:
Collegeville, 19426, US
Name:
Lebowitz, PeterAddress:
Collegeville, 19426, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
25221309 PDate:
16.10.2009Country:
US
Classification
Categories:
A61K 31/519, A61K 31/506, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 15
Paid: 12.8.2024
Expires: 14.10.2025
Payer: Árnason Faktor ehf.